
Shares of Perspective Therapeutics Inc dipped 0.8% to $4.22 in early premarket trade on Friday, following a strong 66.4% gain to $4.26 the day before, according to MarketBeat data.
Samsung and Alibaba Rout Deepens as India Slips Below 24,200
Nikkei Trims Loss as Alibaba and Samsung Pressure Asia Tech
India’s Firm Open Fails to Offset Alibaba-Samsung Tech Shock
Alibaba Dilution and Samsung Disappointment Deepen Asia Tech Selloff
Alibaba’s AI Placement Deepens Asia’s Heavyweight Selloff
Today’s highest-ranked model selections.
The catalysts most likely to move markets.
A surprise around the 0.10 forecast could shift the morning growth narrative and influence Treasury yields and the dollar before the opening bell.
The day’s largest scheduled equity report can move PDD and the broader China-internet / e-commerce complex through revenue growth, margins and Temu commentary.
Deliveries, margin progression and spending on AI-enabled mobility can affect U.S.-traded Chinese EV names and related technology suppliers.